Heranova – Lifesciences

logo

news + events

08.08.2024

Heranova™ Launches Early Access Program for HerResolve™, a Potential First FDA-Cleared, Non-Invasive Endometriosis Test

06.18.2024

Heranova™ Appoints Dr. Marcel van Duin as Chief Scientific Officer

03.28.2024

Heranova™ Lifesciences Debuts with $13.5 Million Seed and Seed+ Round Funding to Offer Integrated Clinical Solutions to Women’s Health